ICD-10 Code B58.82 | Toxoplasma myositis Symptoms, Diagnosis, Billing

Toxoplasma myositis is an inflammatory condition of the muscles caused by the Toxoplasma gondii parasite. It is clinically significant due to its potential to cause severe muscle pain and weakness, particularly in immunocompromised individuals. Accurate coding with ICD-10 Code B58.82 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B58.82 for Toxoplasma myositis?

ICD-10 Code B58.82 specifically represents Toxoplasma myositis, which is a muscle inflammation resulting from infection with Toxoplasma gondii. This code should be used in clinical documentation and billing when a patient presents with muscle symptoms linked to this parasitic infection, particularly in cases involving immunocompromised patients or those with underlying conditions that may exacerbate the infection.

ICD-10 Code B58.82 – Clinical Definition and Explanation of Toxoplasma myositis

Toxoplasma myositis is primarily caused by the Toxoplasma gondii parasite, which can lead to muscle inflammation and pain. The condition often progresses in immunocompromised individuals, necessitating prompt medical attention to prevent severe complications.

Key Clinical Features:

• Muscle pain and tenderness, particularly in the proximal muscles.
• Weakness and fatigue, often exacerbated by physical activity.
• Possible fever and systemic symptoms in acute cases.
• History of immunosuppression or recent exposure to Toxoplasma.

ICD-10 Code B58.82 for Toxoplasma myositis – SOAP Notes & Clinical Use

ICD-10 Code B58.82 is utilized in SOAP notes to document the presence of Toxoplasma myositis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B58.82 for Toxoplasma myositis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B58.82 connects subjective reports of muscle pain and weakness with objective clinical findings, facilitating a formal diagnosis. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B58.82 – Toxoplasma myositis

Toxoplasma myositis requires prompt treatment to mitigate symptoms and prevent complications. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

• Pyrimethamine combined with sulfadiazine for 4-6 weeks.
• Clindamycin as an alternative for patients allergic to sulfa drugs.
• Consideration of leucovorin to prevent bone marrow suppression.

Supportive Care:

• Pain management with NSAIDs or acetaminophen.
• Physical therapy to maintain muscle function.
• Hydration and nutritional support as needed.

Infection Control:

• Standard precautions to prevent transmission.
• Education on avoiding undercooked meat and unwashed produce.
• Monitoring for outbreaks in immunocompromised populations.

How to Document Symptoms of Toxoplasma myositis (ICD-10 B58.82) in SOAP Notes

Subjective:

• Patient reports muscle pain and weakness, particularly in the legs.
• History of recent exposure to cats or undercooked meat.
• Complaints of fatigue and fever over the past week.

Objective:

• Physical examination reveals proximal muscle tenderness.
• Elevated creatine kinase levels indicating muscle damage.
• Fever of 101°F noted during assessment.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Toxoplasma myositis (ICD-10 Code B58.82)

Assessment:

• Diagnosis: Toxoplasma myositis, moderate severity.
• ICD-10 Code: B58.82.
• Contributing factors: Immunocompromised status due to recent chemotherapy.

Plan:

• Initiate treatment with pyrimethamine and sulfadiazine.
• Provide education on dietary precautions to prevent reinfection.
• Schedule follow-up in 2 weeks to monitor treatment response.

Treatment & Plan Section for ICD-10 Code B58.82 – Toxoplasma myositis

• First-line pharmacologic treatment includes pyrimethamine and sulfadiazine.
• Non-pharmacologic strategies involve physical therapy and nutritional support.
• Monitoring includes regular assessment of muscle strength and function.
• Follow-up appointments to evaluate treatment efficacy and adjust as necessary.

Using ICD-10 Code B58.82 for Toxoplasma myositis in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical presentation and severity.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond with the services provided.

Related ICD-10 Codes Often Used with Toxoplasma myositis

• B58.81 – Toxoplasma encephalitis
• B58.83 – Toxoplasma retinochoroiditis
• B58.89 – Other manifestations of Toxoplasma infection

ICD-10 Code B58.82 in Medical Billing and Insurance for Toxoplasma myositis

ICD-10 Code B58.82 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and clinical findings.
• Use the code in conjunction with relevant CPT codes for comprehensive billing.
• Highlight any complications or comorbidities that may affect treatment.

Common CPT Pairings: